Literature DB >> 6146334

The oral clearance and beta-adrenoceptor antagonist activity of propranolol after single dose are not related to debrisoquine oxidation phenotype.

M S Lennard, P R Jackson, S Freestone, L E Ramsay, G T Tucker, H F Woods.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6146334      PMCID： PMC1463267          DOI： 10.1111/j.1365-2125.1984.tb02441.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine.

Authors:  M W Lo; B Silber; S Riegelman
Journal:  J Chromatogr Sci       Date:  1982-03       Impact factor: 1.618

2.  Oxidation phenotype--a major determinant of metoprolol metabolism and response.

Authors:  M S Lennard; J H Silas; S Freestone; L E Ramsay; G T Tucker; H F Woods
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245
  2 in total
  2 in total

1.  Polymorphic metabolism of beta-adrenoceptor antagonists.

Authors:  J H Silas; M S Lennard; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 2.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.